Cargando…
Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
BACKGROUND: With many atypical antipsychotics now available in the market, it has become a common clinical practice to switch between atypical agents as a means of achieving the best clinical outcomes. This study aimed to examine the impact of switching from olanzapine to risperidone and vice versa...
Autores principales: | Hong, Jihyung, Novick, Diego, Brugnoli, Roberto, Karagianis, Jamie, Dossenbach, Martin, Haro, Josep Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536691/ https://www.ncbi.nlm.nih.gov/pubmed/23206324 http://dx.doi.org/10.1186/1471-244X-12-218 |
Ejemplares similares
-
Risk factors for suicide behaviors in the observational schizophrenia outpatient health outcomes (SOHO) study
por: Brugnoli, Roberto, et al.
Publicado: (2012) -
Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
por: Ascher-Svanum, Haya, et al.
Publicado: (2014) -
Vice Versa
Publicado: (1869) -
Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
por: Ye, Wenyu, et al.
Publicado: (2012) -
Cannabis-induced psychosis masquerading schizophrenia or vice-versa? A diagnostic dilemma
por: Sharma, Rachit, et al.
Publicado: (2021)